India, March 19 -- Sovereign Pharma

New Delhi [India], March 19: Sovereign Pharma, a leader in high-quality injectable manufacturing, proudly announces its milestone: EU approval for aseptic and terminally sterilized products, including vials, ampoules, cartridges, and pre-filled syringes (PFS) for both liquid and lyophilized formulations. This achievement is a significant step in the company's commitment to quality, safety, and global healthcare excellence.

The EU approval joins ANVISA (Brazil) and MHRA (UK) certifications, all three secured over the course of a year. With these three prestigious approvals, Sovereign Pharma has strengthened its global presence, ensuring its products meet the highest international regulatory standards....